Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,734

Participants

Timeline

Start Date

March 21, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Post ERCP Pancreatitis
Interventions
DEVICE

pancreatic stenting

"a PD stent to be inserted during ERCP (a 3 to 5 cm 5Fr single pigtail pancreatic duct stent without inner flap is used, the stent is inserted after deep cannulation of pancreatic duct with a .025 or .035 wire)"

DRUG

Indomethacin

rectally administered indomethacin before or after ERCP

Trial Locations (7)

200000

RECRUITING

Eastern Hepatobiliary Surgery Hospital,Endoscopy centre, Shanghai

NOT_YET_RECRUITING

Endoscopy centre, Shanghai

300000

RECRUITING

Endoscopy centre, Tianjin

310013

RECRUITING

Endoscopy centre, Hangzhou

710000

RECRUITING

Endoscopy centre, Xi'an

Unknown

RECRUITING

Endoscopy Centre, Prince of Wales Hospital, Hong Kong

RECRUITING

2. Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok

All Listed Sponsors
collaborator

Xijing Hospital

OTHER

collaborator

Changhai Hospital

OTHER

collaborator

Tianjin Union Medical Center

OTHER

collaborator

Zhejiang University

OTHER

collaborator

Eastern Hepatobiliary Surgery Hospital

OTHER

lead

Chinese University of Hong Kong

OTHER